MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date

Wednesday, September 25, 2019

1:15pm-2:45pm
No link between striatal dopaminergic axons and dopamine transporter imaging in Parkinson’s disease

E. Honkanen, L. Saari, K. Orte, M. Gardberg, T. Noponen, J. Joutsa, V. Kaasinen (Turku, Finland)

Neuroimaging  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
Non motor fluctuations in Parkinson’s disease: Findings from a Tunisian cohort

M. Ben Djebara, K. Laabidi, A. Nasri, A. Rekik, S. Mrabet, A. Gargouri, I. Kacem, R. Gouider (Tunis, Tunisia)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
1:15pm-2:45pm
Non motor symptoms Parkinson’s disease

N. Bagdanova, Z. Zuleiha (Kazan, Russian Federation)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
1:15pm-2:45pm
Non-Invasive Vagus Nerve Stimulation: A non-pharmacological approach to target gait impairment in Parkinson’s disease?

A. Yarnall, R. Morris, H. Hunter, JP. Taylor, M. Baker, L. Rochester (Newcastle Upon Tyne, United Kingdom)

Non-Pharmacological Interventions  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
Non-motor symptoms burden grading in Parkinson disease with the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS)

D. Weintraub, C. Rodriguez-Blazquez, A. Schrag, A. Rizos, KR. Chaudhuri, P. Martinez-Martin (Madrid, Spain)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
1:15pm-2:45pm
Non-motor symptoms burden is greater in early Parkinson’s disease patients with motor complications

D. Santos, T. de Deus, E. Suárez Castro, A. Aneiros, S. Jesús, M. Aguilar, LL. Planellas, J. García Caldentey, N. Caballol, B. Vives, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, MA. Avila, MJ. Catalán, L. López Díaz, JM. García Moreno, B. Solano, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo, JC. Martínez Castrillo, P. Sánchez Alonso, MG. Alonso Losada, N. López Ariztegui, P. Martínez Martín, SG. Coppadis (A Coruña, Spain)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
1:15pm-2:45pm
Non-motor Symptoms in Hyperkinetic Movement Disorders

H. Egit, M. Balal, M. Demirkiran (Adana, Turkey)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
1:15pm-2:45pm
Non-motor symptoms in Parkinson disease motor subtypes: a study using the new MDS-NMS

P. Martinez-Martin, C. Rodriguez-Blazquez, A. Schrag, D. Weintraub, A. Rizos, KR. Chaudhuri (Madrid, Spain)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
1:15pm-2:45pm
Non-Motor Symptoms in Patients with Parkinson’s Disease: Effect of Gender, Disease Severity, and Disease Phenotype

V. Holla, A. Lenka, S. Chaithra, A. Stezin, S. Prasad, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
1:15pm-2:45pm
Nonmotor Symptoms in Parkinson’s Disease: 36-month Follow-up Study Comparing Bilateral Subthalamic Stimulation and Standard-of-care Medication

S. Jost, A. Sauerbier, K. Ray-Chaudhuri, V. Visser-Vandewalle, K. Ashkan, M. Silverdale, J. Evans, A. Rizos, A. Schnitzler, P. Löhrer, JN. Petry-Schmelzer, M. Barbe, A. Antonini, P. Martinez-Martin, G. Fink, L. Timmermann, H. Dafsari (Cologne, Germany)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
  • «Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 67
  • Next Page»

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley